Soligenix
SNGX
#10201
Rank
C$17.01 M
Marketcap
C$1.69
Share price
0.82%
Change (1 day)
-50.27%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -C$17.45 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$12.82 Million a decrease over its 2023 earnings that were of -C$10.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$17.45 Million36.12%
2024 -C$12.82 Million22.96%
2023 -C$10.43 Million-45.74%
2022 -C$19.21 Million11.88%
2021 -C$17.17 Million-32.37%
2020 -C$25.39 Million83.18%
2019 -C$13.86 Million11.57%
2018 -C$12.43 Million19.29%
2017 -C$10.42 Million33%
2016 -C$7.83 Million-19.7%
2015 -C$9.75 Million5.16%
2014 -C$9.28 Million
2010 -C$10.47 Million26.12%
2009 -C$8.3 Million75.1%
2008 -C$4.74 Million-45.38%
2007 -C$8.68 Million-22.84%
2006 -C$11.25 Million66.15%
2005 -C$6.77 Million-16.65%
2004 -C$8.12 Million13.28%
2003 -C$7.17 Million-11.88%
2002 -C$8.14 Million-59.44%
2001 -C$20.06 Million378.18%
2000 -C$4.2 Million-38.53%
1999 -C$6.83 Million-18.43%
1998 -C$8.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.41 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.25 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.47 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-C$24.9 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$57.27 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.95 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-C$3.78 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA